Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alma Ramić

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|January 18, 2012
Preparation of novel meta- and para-substituted N-benzyl protected quinuclidine esters and their resolution with butyrylcholinesteraseInes Primožič, Marijana Bolant, Alma Ramić, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Structure-Function Insights into Quinuclidine-3-One BisQACs: Synthesis, Modulation of Bacterial Resistance, Structure-Activity Relationship, and Biological ProfilingAntonio Sabljić, Doris Čarija, Alma Ramić, et al.
Molecules (Basel, Switzerland)|July 25, 2017
New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus CompoundsMaja Katalinić, Antonio Zandona, Alma Ramić, et al.
Molecules (Basel, Switzerland)|May 23, 2018
Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative BacteriaMirjana Skočibušić, Renata Odžak, Alma Ramić, et al.
Plos One|October 6, 2018
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffoldAnita Bosak, Alma Ramić, Tamara Šmidlehner, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated <i>Cinchona</i> Alkaloid-Based Derivatives as Cholinesterase InhibitorsAlma Ramić, Ana Matošević, Barbara Debanić, et al.
International Journal of Molecular Sciences|January 11, 2024
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell ViabilitySuzana Žunec, Donna Vadlja, Alma Ramić, et al.
Scientific Reports|November 1, 2024
Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agentsDoris Crnčević, Alma Ramić, Andreja Radman Kastelic, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Antimicrobial Activity of Quasi-Enantiomeric <i>Cinchona</i> Alkaloid Derivatives and Prediction Model Developed by Machine LearningAlma Ramić, Mirjana Skočibušić, Renata Odžak, et al.
European Journal of Medicinal Chemistry|May 3, 2026
N,N'-dibenzyl imidazolium oximes are potent reactivators of organophosphate-inhibited human butyrylcholinesteraseDora Kolić, Toni Divjak, Goran Šinko, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|January 18, 2012
Preparation of novel meta- and para-substituted N-benzyl protected quinuclidine esters and their resolution with butyrylcholinesteraseInes Primožič, Marijana Bolant, Alma Ramić, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Structure-Function Insights into Quinuclidine-3-One BisQACs: Synthesis, Modulation of Bacterial Resistance, Structure-Activity Relationship, and Biological ProfilingAntonio Sabljić, Doris Čarija, Alma Ramić, et al.
Molecules (Basel, Switzerland)|July 25, 2017
New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus CompoundsMaja Katalinić, Antonio Zandona, Alma Ramić, et al.
Molecules (Basel, Switzerland)|May 23, 2018
Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative BacteriaMirjana Skočibušić, Renata Odžak, Alma Ramić, et al.
Plos One|October 6, 2018
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffoldAnita Bosak, Alma Ramić, Tamara Šmidlehner, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated <i>Cinchona</i> Alkaloid-Based Derivatives as Cholinesterase InhibitorsAlma Ramić, Ana Matošević, Barbara Debanić, et al.
International Journal of Molecular Sciences|January 11, 2024
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell ViabilitySuzana Žunec, Donna Vadlja, Alma Ramić, et al.
Scientific Reports|November 1, 2024
Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agentsDoris Crnčević, Alma Ramić, Andreja Radman Kastelic, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Antimicrobial Activity of Quasi-Enantiomeric <i>Cinchona</i> Alkaloid Derivatives and Prediction Model Developed by Machine LearningAlma Ramić, Mirjana Skočibušić, Renata Odžak, et al.
European Journal of Medicinal Chemistry|May 3, 2026
N,N'-dibenzyl imidazolium oximes are potent reactivators of organophosphate-inhibited human butyrylcholinesteraseDora Kolić, Toni Divjak, Goran Šinko, et al.
Pageof 1